Company Filing History:
Years Active: 2001
Title: Alan Schmaljohn: Innovator in Genetic Vaccine Methodology
Introduction
Alan Schmaljohn is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of immunology, particularly in the development of genetic vaccines. His innovative approach focuses on enhancing the immune response against viral infections.
Latest Patents
Alan Schmaljohn holds a patent for "Genetic induction of anti-viral immune response and genetic vaccine for filovirus." This patent describes a methodology for genetic vaccination, where a genetic construction encoding antigenic determinants of a filovirus is transfected into the cells of vaccinated individuals. The process utilizes a particle acceleration protocol to express viral antigens in healthy cells, thereby eliciting a robust immune response.
Career Highlights
Throughout his career, Schmaljohn has been associated with Powerject Vaccines Inc., where he has worked on advancing vaccine technologies. His research has been pivotal in understanding how genetic vaccines can be utilized to combat viral diseases effectively.
Collaborations
Some of his notable coworkers include Joel R Haynes and Connie S Schmaljohn, who have collaborated with him on various projects related to vaccine development.
Conclusion
Alan Schmaljohn's work in genetic vaccine methodology represents a significant advancement in the fight against viral infections. His innovative approaches continue to inspire future research in immunology and vaccine development.